Selective inhibition of histone deacetylase 10: hydrogen bonding to the gatekeeper residue is implicated
The discovery of isozyme-selective histone deacetylase (HDAC) inhibitors is critical for understanding the biological functions of individual HDACs and for validating HDACs as drug targets. The isozyme HDAC10 contributes to chemotherapy resistance and has recently been described to be a polyamine de...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
April 9, 2019
|
| In: |
Journal of medicinal chemistry
Year: 2019, Volume: 62, Issue: 9, Pages: 4426-4443 |
| ISSN: | 1520-4804 |
| DOI: | 10.1021/acs.jmedchem.8b01936 |
| Online Access: | Verlag, Pay-per-use, Volltext: https://doi.org/10.1021/acs.jmedchem.8b01936
|
| Author Notes: | Magalie Géraldy, Michael Morgen, Peter Sehr, Raphael R. Steimbach, Davide Moi, Johannes Ridinger, Ina Oehme, Olaf Witt, Mona Malz, Mauro S. Nogueira, Oliver Koch, Nikolas Gunkel, and Aubry K. Miller |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1670462994 | ||
| 003 | DE-627 | ||
| 005 | 20230426082349.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190801s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1021/acs.jmedchem.8b01936 |2 doi | |
| 035 | |a (DE-627)1670462994 | ||
| 035 | |a (DE-599)KXP1670462994 | ||
| 035 | |a (OCoLC)1341235205 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 30 |2 sdnb | ||
| 100 | 1 | |a Géraldy, Magalie |e VerfasserIn |0 (DE-588)1191946762 |0 (DE-627)1670465187 |4 aut | |
| 245 | 1 | 0 | |a Selective inhibition of histone deacetylase 10 |b hydrogen bonding to the gatekeeper residue is implicated |c Magalie Géraldy, Michael Morgen, Peter Sehr, Raphael R. Steimbach, Davide Moi, Johannes Ridinger, Ina Oehme, Olaf Witt, Mona Malz, Mauro S. Nogueira, Oliver Koch, Nikolas Gunkel, and Aubry K. Miller |
| 264 | 1 | |c April 9, 2019 | |
| 300 | |a 18 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 01.08.2019 | ||
| 520 | |a The discovery of isozyme-selective histone deacetylase (HDAC) inhibitors is critical for understanding the biological functions of individual HDACs and for validating HDACs as drug targets. The isozyme HDAC10 contributes to chemotherapy resistance and has recently been described to be a polyamine deacetylase, but no studies toward selective HDAC10 inhibitors have been published. Using two complementary assays, we found Tubastatin A, an HDAC6 inhibitor, to potently bind HDAC10. We synthesized Tubastatin A derivatives and found that a basic amine in the cap group was required for strong HDAC10 binding. HDAC10 inhibitors mimicked knockdown by causing dose-dependent accumulation of acidic vesicles in a neuroblastoma cell line. Furthermore, docking into human HDAC10 homology models indicated that a hydrogen bond between a cap group nitrogen and the gatekeeper residue Glu272 was responsible for potent HDAC10 binding. Taken together, our data provide an optimal platform for the development of HDAC10-selective inhibitors, as exemplified with the Tubastatin A scaffold. | ||
| 700 | 1 | |a Morgen, Michael |e VerfasserIn |0 (DE-588)1043231331 |0 (DE-627)770438601 |0 (DE-576)394588401 |4 aut | |
| 700 | 1 | |a Ridinger, Johannes |e VerfasserIn |0 (DE-588)1162237341 |0 (DE-627)1025709357 |0 (DE-576)507290496 |4 aut | |
| 700 | 1 | |a Oehme, Ina |d 1974- |e VerfasserIn |0 (DE-588)129573388 |0 (DE-627)473352621 |0 (DE-576)297728652 |4 aut | |
| 700 | 1 | |a Witt, Olaf |d 1965- |e VerfasserIn |0 (DE-588)17275030X |0 (DE-627)697681750 |0 (DE-576)133607410 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of medicinal chemistry |d Washington, DC : ACS, 1959 |g 62(2019), 9, Seite 4426-4443 |h Online-Ressource |w (DE-627)302468846 |w (DE-600)1491411-6 |w (DE-576)090855132 |x 1520-4804 |7 nnas |a Selective inhibition of histone deacetylase 10 hydrogen bonding to the gatekeeper residue is implicated |
| 773 | 1 | 8 | |g volume:62 |g year:2019 |g number:9 |g pages:4426-4443 |g extent:18 |a Selective inhibition of histone deacetylase 10 hydrogen bonding to the gatekeeper residue is implicated |
| 856 | 4 | 0 | |u https://doi.org/10.1021/acs.jmedchem.8b01936 |x Verlag |x Resolving-System |z Pay-per-use |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190801 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 17275030X |a Witt, Olaf |m 17275030X:Witt, Olaf |d 910000 |d 910500 |e 910000PW17275030X |e 910500PW17275030X |k 0/910000/ |k 1/910000/910500/ |p 8 | ||
| 998 | |g 129573388 |a Oehme, Ina |m 129573388:Oehme, Ina |d 50000 |e 50000PO129573388 |k 0/50000/ |p 7 | ||
| 998 | |g 1162237341 |a Ridinger, Johannes |m 1162237341:Ridinger, Johannes |d 910000 |d 910500 |e 910000PR1162237341 |e 910500PR1162237341 |k 0/910000/ |k 1/910000/910500/ |p 6 | ||
| 998 | |g 1043231331 |a Morgen, Michael |m 1043231331:Morgen, Michael |d 140000 |e 140000PM1043231331 |k 0/140000/ |p 2 | ||
| 999 | |a KXP-PPN1670462994 |e 3502533407 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1021/acs.jmedchem.8b01936"],"eki":["1670462994"]},"recId":"1670462994","name":{"displayForm":["Magalie Géraldy, Michael Morgen, Peter Sehr, Raphael R. Steimbach, Davide Moi, Johannes Ridinger, Ina Oehme, Olaf Witt, Mona Malz, Mauro S. Nogueira, Oliver Koch, Nikolas Gunkel, and Aubry K. Miller"]},"origin":[{"dateIssuedDisp":"April 9, 2019","dateIssuedKey":"2019"}],"language":["eng"],"note":["Gesehen am 01.08.2019"],"person":[{"given":"Magalie","family":"Géraldy","role":"aut","display":"Géraldy, Magalie"},{"display":"Morgen, Michael","role":"aut","family":"Morgen","given":"Michael"},{"given":"Johannes","family":"Ridinger","role":"aut","display":"Ridinger, Johannes"},{"display":"Oehme, Ina","family":"Oehme","role":"aut","given":"Ina"},{"role":"aut","family":"Witt","display":"Witt, Olaf","given":"Olaf"}],"relHost":[{"title":[{"title_sort":"Journal of medicinal chemistry","title":"Journal of medicinal chemistry"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"extent":"18","issue":"9","pages":"4426-4443","year":"2019","volume":"62","text":"62(2019), 9, Seite 4426-4443"},"language":["eng"],"pubHistory":["1.1959 -"],"note":["Gesehen am 02.10.2020"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"302468846","id":{"issn":["1520-4804"],"eki":["302468846"],"zdb":["1491411-6"]},"name":{"displayForm":["American Chemical Society"]},"origin":[{"dateIssuedDisp":"1959-","dateIssuedKey":"1959","publisherPlace":"Washington, DC ; Easton, Pa.","publisher":"ACS ; ACS"}],"disp":"Selective inhibition of histone deacetylase 10 hydrogen bonding to the gatekeeper residue is implicatedJournal of medicinal chemistry"}],"title":[{"title_sort":"Selective inhibition of histone deacetylase 10","subtitle":"hydrogen bonding to the gatekeeper residue is implicated","title":"Selective inhibition of histone deacetylase 10"}],"physDesc":[{"extent":"18 S."}]} | ||
| SRT | |a GERALDYMAGSELECTIVEI9201 | ||